Discovery and Biological Evaluation of Novel Dual EGFR/c-Met Inhibitors

[Image: see text] Activating mutations in the epidermal growth factor receptor (EGFR) have been identified in a subset of non-small cell lung cancer (NSCLC), which is one of the leading cancer types worldwide. Application of EGFR tyrosine kinase inhibitors leads to acquired resistance by secondary E...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Szokol, Bálint, Gyulavári, Pál, Kurkó, Ibolya, Baska, Ferenc, Szántai-Kis, Csaba, Greff, Zoltán, Őrfi, Zoltán, Peták, István, Pénzes, Kinga, Torka, Robert, Ullrich, Axel, Őrfi, László, Vántus, Tibor, Kéri, György
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: American Chemical Society 2014
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4027597/
https://ncbi.nlm.nih.gov/pubmed/24900830
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/ml4003309
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller